29191068 11479048 34083861 18456777 15001254 26321404 21883142 12057122 11157031 18716396 24285015 1931709 22311555 7741545 10506727 9839342 10456338 9684929 8156170 11707865 12057060 10607318 2011657 11346336 11561692 16574401 17822499 7605995 11707 - Search Results

Year	Number of Results
1989	1
1990	6
1991	15
1992	11
1993	6
1994	12
1995	17
1996	16
1997	11
1998	13
1999	13
2000	20
2001	17
2002	15
2003	14
2004	10
2005	13
2006	18
2007	9
2008	13
2009	8
2010	12
2011	11
2012	14
2013	14
2014	14
2015	11
2016	8
2017	7
2018	7
2019	8
2020	9
2021	12
2022	6
2023	1

1

An exploratory cost-effectiveness analysis of systemic treatments for cutaneous T-cell lymphoma.

Geskin L, Malone DC. Geskin L, et al. J Dermatolog Treat. 2018 Aug;29(5):522-530. doi: 10.1080/09546634.2017.1412064. Epub 2017 Dec 18. J Dermatolog Treat. 2018. PMID: 29191068

2

Total skin electron beam therapy in the management of cutaneous malignancies.

Ravi A, Nisce LZ, Nori D. Ravi A, et al. Clin Dermatol. 2001 May-Jun;19(3):354-6. doi: 10.1016/s0738-081x(01)00167-5. Clin Dermatol. 2001. PMID: 11479048 Review. No abstract available.

3

Monte Carlo (MC) study of dose distribution and Cherenkov imaging in total skin electron therapy (TSET) with TOPAS.

Zhong W, Ong YH, Zhu T. Zhong W, et al. Proc SPIE Int Soc Opt Eng. 2021 Mar;11628:116280S. doi: 10.1117/12.2583397. Epub 2021 Mar 12. Proc SPIE Int Soc Opt Eng. 2021. PMID: 34083861 Free PMC article.

4

Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Dummer R, Dreyling M; ESMO Guidelines Working Group. Dummer R, et al. Ann Oncol. 2008 May;19 Suppl 2:ii72-6. doi: 10.1093/annonc/mdn095. Ann Oncol. 2008. PMID: 18456777 Free article. No abstract available.

5

Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).

Ysebaert L, Truc G, Dalac S, Lambert D, Petrella T, Barillot I, Naudy S, Horiot JC, Maingon P. Ysebaert L, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1128-34. doi: 10.1016/j.ijrobp.2003.08.007. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001254

6

Systemic involvement in mycosis fungoides.

Burg G. Burg G. Clin Dermatol. 2015 Sep-Oct;33(5):563-71. doi: 10.1016/j.clindermatol.2015.05.008. Epub 2015 Jun 1. Clin Dermatol. 2015. PMID: 26321404 Review.

7

Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Wong HK, Mishra A, Hake T, Porcu P. Wong HK, et al. Br J Haematol. 2011 Oct;155(2):150-66. doi: 10.1111/j.1365-2141.2011.08852.x. Epub 2011 Aug 25. Br J Haematol. 2011. PMID: 21883142 Free PMC article. Review.

8

T-small cell disorders.

Westin EH, Longo DL. Westin EH, et al. Curr Treat Options Oncol. 2001 Jun;2(3):225-35. doi: 10.1007/s11864-001-0036-2. Curr Treat Options Oncol. 2001. PMID: 12057122 Review.

9

Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides.

de Coninck EC, Kim YH, Varghese A, Hoppe RT. de Coninck EC, et al. J Clin Oncol. 2001 Feb 1;19(3):779-84. doi: 10.1200/JCO.2001.19.3.779. J Clin Oncol. 2001. PMID: 11157031

10

Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.

Kahata K, Hashino S, Takahata M, Fujisawa F, Kondo T, Kobayashi S, Fujita Y, Shimizu H, Imamura M, Asaka M. Kahata K, et al. Acta Haematol. 2008;120(1):14-8. doi: 10.1159/000151510. Epub 2008 Aug 21. Acta Haematol. 2008. PMID: 18716396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results